Pregnancy and foetal outcome after bariatric surgery: a review of recent studies

Insights

Bariatric surgery in morbidly obese pregnant women improves pregnancy outcomes and reduces childhood obesity rates. However, specific surgical types carry different risks, requiring careful monitoring and multidisciplinary nutritional support.

Area of Science:

  • Obstetrics and Gynecology
  • Bariatric Surgery
  • Neonatal Health

Background:

  • Maternal obesity poses significant risks to offspring's immediate and long-term health.
  • Bariatric surgery offers potential benefits for morbidly obese pregnant women and their children.

Purpose of the Study:

  • To review the role, risks, and benefits of bariatric surgery in morbidly obese pregnant women.
  • To assess the impact of different bariatric procedures on maternal and neonatal outcomes.

Main Methods:

  • Literature review assessing pregnancy and neonatal outcomes after various bariatric procedures.
  • Analysis of maternal complications, nutritional status, and infant health data.

Main Results:

  • Pregnancy outcomes vary by bariatric surgery type; Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion (BPD) show higher maternal complication rates than laparoscopic adjustable gastric banding (LAGB).
  • RYGB is associated with increased rates of cesarean section, preterm delivery, and neonatal death compared to LAGB.
  • Long-term follow-up shows a 52% reduction in childhood obesity and a 45% decrease in severe obesity after maternal bariatric surgery.
  • Bariatric surgery is more effective than diet alone for morbidly obese women, generally leading to favorable pregnancy outcomes.

Conclusions:

  • Pregnancies after bariatric surgery generally have favorable outcomes but require specialized medical attention.
  • Increased risks include gastrointestinal symptoms and vitamin deficiencies, necessitating multidisciplinary nutritional counseling before, during, and after pregnancy.
  • The choice of bariatric procedure significantly influences maternal and neonatal risks and benefits.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...